Literature DB >> 2941361

Elevated antibody-dependent cell-mediated cytotoxicity and its inhibition by nicotinamide in the diabetic NOD mouse.

H Nakajima, K Yamada, T Hanafusa, H Fujino-Kurihara, J Miyagawa, A Miyazaki, R Saitoh, Y Minami, N Kono, K Nonaka.   

Abstract

Antibody-dependent cell-mediated cytotoxicity (ADCC) by splenic mononuclear cells was measured in female non-obese diabetic (NOD) mice and age-matched ICR mice. No significant difference in ADCC activities was observed between the two groups when all the NOD mice were pre-diabetic. ADCC activities in diabetic NOD mice were significantly higher than those in age-matched ICR mice (P less than 0.001). Nicotinamide, known to prevent the diabetes of the NOD mouse, strongly inhibited ADCC by the mononuclear cells from diabetic NOD mice. Kinetic studies revealed that the inhibition was non-competitive.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2941361     DOI: 10.1016/0165-2478(86)90088-x

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  6 in total

1.  The non-obese diabetic (NOD) mouse.

Authors:  E H Leiter; M Prochazka; D L Coleman
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

2.  Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy.

Authors:  S Schröder; W Palinski; G W Schmid-Schönbein
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

Review 3.  Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide.

Authors:  Seon Beom Song; Jin Sung Park; Gu June Chung; In Hye Lee; Eun Seong Hwang
Journal:  Metabolomics       Date:  2019-10-05       Impact factor: 4.290

Review 4.  Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type 1 (insulin-dependent) diabetes mellitus.

Authors:  E F Lampeter; A Signore; E A Gale; P Pozzilli
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

5.  Protective effects of a nicotinamide derivative, isonicotinamide, against streptozotocin-induced β-cell damage and diabetes in mice.

Authors:  Makiko Fukaya; Yoshiaki Tamura; Yuko Chiba; Toshihiro Tanioka; Ji Mao; Yoko Inoue; Marina Yamada; Christian Waeber; Yukari Ido-Kitamura; Tadahiro Kitamura; Masao Kaneki
Journal:  Biochem Biophys Res Commun       Date:  2013-11-15       Impact factor: 3.575

Review 6.  Possible Adverse Effects of High-Dose Nicotinamide: Mechanisms and Safety Assessment.

Authors:  Eun Seong Hwang; Seon Beom Song
Journal:  Biomolecules       Date:  2020-04-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.